Analysis: Warsh rate hike reinforces Fed independence after Trump pressure Americans' incomes rose and poverty fell in 2025, Census Bureau says OpenAI CFO Sarah Friar emphasizes 'need to take safety seriously' on AI risks Elon Musk, the world’s richest man, says he’s living in an Airstream trailer to oversee xAI’s biggest expansion yet Dominant Kerr wins $150K with GB's first Ultimate title Amid war and sanctions, many Iranians are losing their jobs and struggling to get by Dan Chung rebuilt a decimated Alger Management after 9/11. He's still finding the market's winners Kenya's foreign trader crackdown sparks fear among migrant communities OpenAI says it cracked one of math’s grand challenges. But there are troubling questions about how they did it—and what it means for us all U.S. debt is even worse than it seems, and rising Treasury yields are now an ‘all-hands-on-deck situation,’ top economist warns

Dennis Bastas

Dennis Bastas

Dennis Bastas (#1141)

Global Rank #1141
Country Rank #17
Country Australia

Dennis Bastas is listed among the world billionaires tracked by Iconic Billionaires.

  • $ 4 B
  • pharmaceuticals
  • Australia
  • M
  • 60 Years

Snapshot

Quick Facts

Global Rank #1,141
Country Rank #17
Net Worth $3.8B
Previous Worth $3.8B
Worth Change +$0.0B
Country Australia
Industry pharmaceuticals
Age 60 Years
Gender M
Worth As Of May 4, 2026
Last Refreshed 12 Sep 2026, 12:00 AM
Residence Victoria, Australia
World Billionaires List Australia Billionaires pharmaceuticals

Profile Data

Personal Stats

Age 60
Source Of Wealth pharmaceuticals, Self Made
Residence Victoria, Australia
Citizenship Australia
Education Bachelor of Engineering, Monash University
Net Worth Change +$0.0B +0.0% from previous worth
Previous Net Worth $3.8B
Current Net Worth $3.8B

Worth as of May 4, 2026

About Me

Dennis Bastas is chairman and group CEO of Australia-based diversified health and beauty company DBG Health. Bastas was born to Greek parents who migrated to Melbourne in 1960s. He began his career in logistics at retailing giant Coles Myer. In the early 2000s he founded Genepharm Australasia, which he later sold to Watson in 2012 for $252 million. In 2023, Bastas' DBG Health acquired three companies including Arrotex Pharmaceuticals, the country's largest pharmaceutical company by market share, for $671 million. In 2025, Bastas sold a stake in DBG Global Enterprises, the holding company of DBG Health, to global merchant bank BDT & MSD Partners for $1 billion, valuing the company at more than $4.7 billion.

Wealth Growth

Net Worth Growth Over Time

Tracking Dennis Bastas's net worth journey over the years, highlighting key growth phases and financial milestones.

© Iconic Billionaires